Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease — Stella

Home/Alcoholic Hepatitis/

View on ClinicalTrials.gov

Recruiting

Back to Alcoholic Hepatitis trials

Trial locations(1 site)

United States

Stanford University Dept. of Medicine -Gastroenterology & Hepatology, Redwood City, California

Key details

Sponsor

HepQuant, LLC

Collaborators

Leland Stanford Junior University

Enrollment target

~40 participants

Started

June 2025

Primary completion

December 2031

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.